Arkolith/Insider Trading/AMAM/Form 4

Cormorant Asset Management, LP

10% OwnerAmbrx Biopharma Inc. (AMAM) · full profile →Form 4 · filed Sep 19, 2023
Net Buying
Open-Market Buys
$19.6M
Open-Market Sells
$0
Net Open-Market Flow
$19.6M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 18, 2023Buy(P)751K$9.24$6.9M69.5M
Sep 15, 2023Buy(P)1.4M$9.05$12.7M68.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000929638-23-002564) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML